Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.

TSX:MSCL - Post by User

Satellos Bioscience Inc > Juansito ???

<< Previous

Bullboard Posts

Next >>

Post by jomagon Jul 31, 2019 9:47am

126 Views

Post# 29978881

Juansito ???

V:ICO Depth by Order @09:46:34

Bid			Ask
Broker	Size	Price	Price	Size	Broker
1 Anonymous	50,000	0.085	0.095	7,500	7 TD Sec
19 Desjardins	100,000	0.085	0.095	10,000	80 National Bank
89 Raymond James	300,000	0.085	0.095	1,000	1 Anonymous
1 Anonymous	1,000	0.085	0.095	100,000	19 Desjardins
19 Desjardins	49,000	0.085	0.10	30,000	2 RBC
80 National Bank	9,500	0.085	0.10	3,000	7 TD Sec
1 Anonymous	100,000	0.08	0.10	57,500	7 TD Sec
1 Anonymous	75,000	0.08	0.10	24,000	2 RBC
2 RBC	25,000	0.08	0.105	10,000	85 Scotia
79 CIBC	10,000	0.08	0.105	11,000	19 Desjardins